Upgrade to SI Premium - Free Trial

Cumberland Pharmaceuticals (CPIX) Reports Q2 Loss of $0.20

August 4, 2026 5:57 PM

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q2 EPS of ($0.20). Revenue for the quarter came in at $166.45 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

Categories

Earnings